Atrimed Pharma Absorbs Dr. Narendra Chirmule, Former Head Of Biocon
Atrimed pharama absorbs Dr. Narendra Chirmule, Former head of Biocon.
- (1888PressRelease) July 19, 2020 - Bangalore based Atrimed Pharmaceuticals today announced the appointment of Dr. Narendra Chirmule to the role of Senior Director effective immediately. Dr. Narendra Chirmule was most recently was the Head of R&D at Biocon (Bangalore), Stated that “I look forward to bringing my experience Into Atrimed Pharmaceuticals, a pioneer in developing scientifically tested medicines from plant based molecules”
Dr. Hrishikesh Damle, M.D- Atrimed Pharma said that “We are pleased to announce that
Dr. Narendra Chirmule is with us now and will be assisting us at Atrimed, as we have exciting lead molecules for Covid, Psoriasis & snake venom neutralisation. In his new role
Dr Chirmule will be guiding us through the next level of studies making them eligible for IND application (Investigational New Drug). Investigational new drug application is the procedure to submit research findings to DCGI (Drugs Controller General of India) for their approval” further he said that “Dr. Chirmule has deep expertise in the area of immunogenicity in biologics and has been involved in shaping the regulatory guidelines for biologics and biosimilars in EU & US.”
Prior to this, Dr. Chirmule has held leadership positions in Amgen (Thousand Oaks, CA) and Merck Vaccines (West Point, PA) has contributed to clinical development of vaccines and biopharmaceuticals. He did a PhD on development of a leprosy vaccine, from Cancer Research Institute, Mumbai with post-doctoral studies on pathogenesis of AIDS from Cornell University Medical College -North Shore Hospital, New York; teaching and research as assistant professor in gene therapy at the University of Pennsylvania. Philadelphia In addition to the experience he brings into Atrimed Dr. Chirmule is on the NIH Advisory committee for HIV Vacceines. Narendra Chirmule is the co-founder and CEO of SymphonyTech Biologics, a data Analytics Company focused on engineering solutions to biology.
About Atrimed Pharma: Bangalore based, 15 year old Atrimed is a pioneer in developing medicines from plant based molecules., takes inspirations from nature and natural product chemistry, to develop drugs that treat diseases which have troubled humanity such as Psoriasis, Acne, Arthritis and more. It combines the inspiration from nature and natural product chemistry, with the knowledge base created from computer aided drug design, biotechnology and Artificial Intelligence to establish a library of plant molecules, some 400,000 strong, the largest in the world. Their products cater to Skin and Hair care, Mother and Child care, and Bone related diseases, Nutrition, Metabolism and Allergies. . The pharmaceutical company was sent to BIO 2019, Philadelphia, USA which is the largest Biotechnology Expo in the world by Government of India “to showcase India’s biotechnological ecosystem and to learn more about the perspectives of various governments, key thought leaders and experts from around the world on the new opportunities and challenges facing the global biotech industry.”
Editorial Contact: Commstrat, email :commstrat.ind ( @ ) gmail dot com, Phone :9342583323
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam